Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles), By Region And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
Nanomedicine Market Growth & Trends
The global nanomedicine market is expected to reach USD 427.18 billion by 2030, registering a CAGR of 11.7% during the forecast period, according to a new report by Grand View Research, Inc. The advantages of nanomedicine in numerous healthcare applications, the emergence of novel drug delivery technologies, and the rise in demand for safe and affordable treatments are the factors contribute to the nanomedicine market's expansion.
One of the main reasons for nanomedicine to become more and more prominent is the rise in the prevalence of chronic diseases like cancer and cardiovascular disease. Additionally, the market for nanomedicine is expanding due to the growing elderly population, an increase in patients with high blood pressure, obesity, and other cardiovascular diseases, as well as other factors.
For instance, The International Agency for Research on Cancer estimates that there are 10.3 million cancer deaths and 19.3 million new cases of cancer worldwide in 2020. Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, out of an estimated 29.5 million new instances of the disease per year.
Need for the nanomedicine to cure a wide range of illnesses has increased due to COVID-19. The development of new approaches intended for the detection, diagnosis, and cure of the COVID-19 virus as well as other viral infections was made possible by the development of nanomedicine applications. For instance, in November 2020, BioNtech and Pfizer announced the full results of phase-3 clinical study for COVID-19 vaccine.
They rapidly manufactured vaccinations for testing and regulatory approval using a known technique for encapsulating therapeutic nucleic acid molecules in lipid Nanoparticles. Additionally, due to the growth in activities intended for the research and development, which are meant for the nanomedicine across all the regions, are fueling the market growth.
The developing technologies for drug delivery are important elements that are expected to accelerate growth of the global market. Also, it is anticipated that the rising popularity of the nanomedicine across a variety of applications will fuel the expansion of the nanomedicine market. Furthermore, it is predicted that the increase in government funding and support will boost the market growth for nanomedicine. On the other hand, it is further anticipated that the delayed approval process will impede the expansion of the market during the timeline. Further potential opportunities for expansion of the market in the upcoming years will be provided by rise in the out-licensing of the Nano drugs and expansion of the healthcare facilities in developing nations. During the past few decades, theUS FDA has authorized commercialization of about 100 nanomedicine applications and devices. As a result, growing interest in nanotechnology's potential medical uses has led to the emergence of a new industry called the nanome
dicine market and further drives the market growth.
The growing investment flow in R&D in this market is reflected in the increasing number of research publications. For instance, in 2021 , the national nanotechnology effort has received more than USD 1.7 billion in financing from the US government, highlighting the significance of the nanotechnology. Additionally, Forbes lists nanotechnology as the sixth most important growth technology to watch over the next ten years.
Further, R&D, and business growth will all be further advanced by the investment. Moreover, these expenditures indicate a better growth opportunity for this market because R&D efforts serve as the foundation for the innovation, thus, propelling the market growth.
Nanomedicine Market Report Highlights
Nanomedicine Market Growth & Trends
The global nanomedicine market is expected to reach USD 427.18 billion by 2030, registering a CAGR of 11.7% during the forecast period, according to a new report by Grand View Research, Inc. The advantages of nanomedicine in numerous healthcare applications, the emergence of novel drug delivery technologies, and the rise in demand for safe and affordable treatments are the factors contribute to the nanomedicine market's expansion.
One of the main reasons for nanomedicine to become more and more prominent is the rise in the prevalence of chronic diseases like cancer and cardiovascular disease. Additionally, the market for nanomedicine is expanding due to the growing elderly population, an increase in patients with high blood pressure, obesity, and other cardiovascular diseases, as well as other factors.
For instance, The International Agency for Research on Cancer estimates that there are 10.3 million cancer deaths and 19.3 million new cases of cancer worldwide in 2020. Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, out of an estimated 29.5 million new instances of the disease per year.
Need for the nanomedicine to cure a wide range of illnesses has increased due to COVID-19. The development of new approaches intended for the detection, diagnosis, and cure of the COVID-19 virus as well as other viral infections was made possible by the development of nanomedicine applications. For instance, in November 2020, BioNtech and Pfizer announced the full results of phase-3 clinical study for COVID-19 vaccine.
They rapidly manufactured vaccinations for testing and regulatory approval using a known technique for encapsulating therapeutic nucleic acid molecules in lipid Nanoparticles. Additionally, due to the growth in activities intended for the research and development, which are meant for the nanomedicine across all the regions, are fueling the market growth.
The developing technologies for drug delivery are important elements that are expected to accelerate growth of the global market. Also, it is anticipated that the rising popularity of the nanomedicine across a variety of applications will fuel the expansion of the nanomedicine market. Furthermore, it is predicted that the increase in government funding and support will boost the market growth for nanomedicine. On the other hand, it is further anticipated that the delayed approval process will impede the expansion of the market during the timeline. Further potential opportunities for expansion of the market in the upcoming years will be provided by rise in the out-licensing of the Nano drugs and expansion of the healthcare facilities in developing nations. During the past few decades, theUS FDA has authorized commercialization of about 100 nanomedicine applications and devices. As a result, growing interest in nanotechnology's potential medical uses has led to the emergence of a new industry called the nanome
dicine market and further drives the market growth.
The growing investment flow in R&D in this market is reflected in the increasing number of research publications. For instance, in 2021 , the national nanotechnology effort has received more than USD 1.7 billion in financing from the US government, highlighting the significance of the nanotechnology. Additionally, Forbes lists nanotechnology as the sixth most important growth technology to watch over the next ten years.
Further, R&D, and business growth will all be further advanced by the investment. Moreover, these expenditures indicate a better growth opportunity for this market because R&D efforts serve as the foundation for the innovation, thus, propelling the market growth.
Nanomedicine Market Report Highlights
- By application, the drug delivery segment accounted for the largest share in 2021. Need for the cutting-edge treatments used for neurological conditions like Parkinson's disease, brain tumors, and Alzheimer's disease will spur additional market expansion for the nanomedicine-based drug delivery systems
- By indication, the clinical oncology segment held a larger share in 2021. Additionally, in comparison to conventional therapies, nanomedicine delivers sensitive cancer detection, improved therapeutic efficacy, and fewer adverse effects. Thus, extensive use of the nanomedicine in oncology will promote the sector's growth
- By molecule type, the nanoparticles segment held a larger share in 2021. The widespread use of the metal & metallic oxides and the utilization of Nanoparticles in various medical settings is expected to encourage expansion in the forecasted years
- North America held the larger share in 2021. This is mostly attributed to the existence of significant market participants, as well as rising R&D spending and federal assistance
- Asia Pacific is expected to grow at the highest rate in a projected time period. Driven by the factors such as rising prevalence of the target diseases with an aging population, increasing nanomedicine adoption and others
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL NANOMEDICINE MARKET VARIABLES, TRENDS, & SCOPE
4.1 Nanomedicine Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Level Of Government Participation In R&D Funding
4.4.2 Introduction Of Technological Advancements In Diagnostic Procedures
4.4.3 Rising Usage Of Nanomedicine In Drug Delivery Technology
4.5 Market Restraint Analysis
4.5.1 Side Effects Associated With Intake Of Nanoparticles And Lower Adoption Rate By Patients
4.5.2 Hesitant Uptake By Medical And Pharmaceutical Industry
4.6 Porter’s Five Forces Analysis
4.7 SWOT Analysis
4.8 COVID-19 Impact Analysis
CHAPTER 5 NANOMEDICINE MARKET- SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
5.1 Global Nanomedicine Market: Application Movement Analysis
5.2 Therapeutics
5.2.1 Therapeutics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Active Implants
5.3.1 Active Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 In-Vitro Diagnostics
5.4.1 In-Vitro Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Drug Delivery
5.5.1 Drug Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 In-Vivo Imaging
5.6.1 In-Vivo Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Implants
5.7.1 Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 NANOMEDICINE MARKET - SEGMENT ANALYSIS, BY INDICATION, 2018 - 2030 (USD MILLION)
6.1 Global Nanomedicine Market: Indication Movement Analysis
6.2 Clinical Oncology
6.2.1 Clinical Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Infectious Diseases
6.3.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Clinical Cardiology
6.4.1 Clinical Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Orthopedics
6.5.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 NANOMEDICINE MARKET - SEGMENT ANALYSIS, BY MOLECULE TYPE, 2018 - 2030 (USD MILLION)
7.1 Nanomedicine Market: Molecule Type Movement Analysis
7.2 Nanoparticles
7.2.1 Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 Metal & Metal Oxide Nanoparticles
7.2.2.1 metal & Metal Oxide NanoparticlesMarket Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3 Liposomes
7.2.3.1 liposomes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.4 Polymers & Polymer Drug Conjugates
7.2.4.1 Polymers & Polymer Drug Conjugates Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.5 Hydrogel Nanoparticles
7.2.5.1 Hydrogel Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.6 Dendrimers
7.2.6.1 Dendrimers Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.7 Inorganic Nanoparticles
7.2.7.1 Inorganic Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Nanoshells
7.3.1 Nanoshells Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Nano Tubes
7.4.1 Nanotubes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Nanodevices
7.5.1 Nanodevices Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 NANOMEDICINE MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 nanomedicine Market: Regional Movement Analysis
8.2 north America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4.France
8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4india
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market estimates and forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 ABBOTT LABORATORIES
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 COMBIMATRIX CORPORATION
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 CELGENE CORPORATION
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 NANOSPECTRA BIOSCIENCES, INC.
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 GENERAL ELECTRIC
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 JOHNSON & JOHNSON SERVICES, INC.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 MALLINCKRODT PHARMACEUTICALS
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 MERCK & CO., INC.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 PFIZER, INC.
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 ARROWHEAD PHARMACEUTICALS, INC.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL NANOMEDICINE MARKET VARIABLES, TRENDS, & SCOPE
4.1 Nanomedicine Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Level Of Government Participation In R&D Funding
4.4.2 Introduction Of Technological Advancements In Diagnostic Procedures
4.4.3 Rising Usage Of Nanomedicine In Drug Delivery Technology
4.5 Market Restraint Analysis
4.5.1 Side Effects Associated With Intake Of Nanoparticles And Lower Adoption Rate By Patients
4.5.2 Hesitant Uptake By Medical And Pharmaceutical Industry
4.6 Porter’s Five Forces Analysis
4.7 SWOT Analysis
4.8 COVID-19 Impact Analysis
CHAPTER 5 NANOMEDICINE MARKET- SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
5.1 Global Nanomedicine Market: Application Movement Analysis
5.2 Therapeutics
5.2.1 Therapeutics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Active Implants
5.3.1 Active Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 In-Vitro Diagnostics
5.4.1 In-Vitro Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Drug Delivery
5.5.1 Drug Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 In-Vivo Imaging
5.6.1 In-Vivo Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Implants
5.7.1 Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 NANOMEDICINE MARKET - SEGMENT ANALYSIS, BY INDICATION, 2018 - 2030 (USD MILLION)
6.1 Global Nanomedicine Market: Indication Movement Analysis
6.2 Clinical Oncology
6.2.1 Clinical Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Infectious Diseases
6.3.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Clinical Cardiology
6.4.1 Clinical Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Orthopedics
6.5.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 NANOMEDICINE MARKET - SEGMENT ANALYSIS, BY MOLECULE TYPE, 2018 - 2030 (USD MILLION)
7.1 Nanomedicine Market: Molecule Type Movement Analysis
7.2 Nanoparticles
7.2.1 Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 Metal & Metal Oxide Nanoparticles
7.2.2.1 metal & Metal Oxide NanoparticlesMarket Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3 Liposomes
7.2.3.1 liposomes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.4 Polymers & Polymer Drug Conjugates
7.2.4.1 Polymers & Polymer Drug Conjugates Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.5 Hydrogel Nanoparticles
7.2.5.1 Hydrogel Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.6 Dendrimers
7.2.6.1 Dendrimers Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.7 Inorganic Nanoparticles
7.2.7.1 Inorganic Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Nanoshells
7.3.1 Nanoshells Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Nano Tubes
7.4.1 Nanotubes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Nanodevices
7.5.1 Nanodevices Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 NANOMEDICINE MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 nanomedicine Market: Regional Movement Analysis
8.2 north America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4.France
8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4india
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market estimates and forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 ABBOTT LABORATORIES
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 COMBIMATRIX CORPORATION
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 CELGENE CORPORATION
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 NANOSPECTRA BIOSCIENCES, INC.
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 GENERAL ELECTRIC
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 JOHNSON & JOHNSON SERVICES, INC.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 MALLINCKRODT PHARMACEUTICALS
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 MERCK & CO., INC.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 PFIZER, INC.
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 ARROWHEAD PHARMACEUTICALS, INC.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
LIST OF TABLES
Table 1 Global Nanomedicine Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 3 Global Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 4 Global Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 5 North America Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 7 North America Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 8 North America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 9 U.S. Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 10 U.S. Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 11 U.S. Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 12 Canada Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 13 Canada Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 14 Canada Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 15 Europe Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 16 Europe Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 17 Europe Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 18 Europe Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 19 UK Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 20 UK Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 21 UK Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 22 Germany Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 23 Germany Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 24 Germany Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 25 France Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 26 France Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 27 France Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 28 Italy Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 29 Italy Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 30 Italy Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 31 Spain Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 32 Spain Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 33 Spain Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 38 Japan Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 39 Japan Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 40 Japan Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 41 China Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 42 China Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 43 China Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 44 India Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 45 India Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 46 India Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 47 Australia Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 48 Australia Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 49 Australia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 50 South Korea Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 51 South Korea Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 52 South Korea Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 53 Latin America Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 54 Latin America Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 55 Latin America Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 56 Latin America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 57 Brazil Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 58 Brazil Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 59 Brazil Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 60 Mexico Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 61 Mexico Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 62 Mexico Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 63 Argentina Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 64 Argentina Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 65 Argentina Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 69 Middle East & Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 70 South Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 71 South Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 72 South Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 76 UAE Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 77 UAE Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 78 UAE Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 1 Global Nanomedicine Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 3 Global Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 4 Global Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 5 North America Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 7 North America Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 8 North America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 9 U.S. Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 10 U.S. Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 11 U.S. Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 12 Canada Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 13 Canada Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 14 Canada Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 15 Europe Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 16 Europe Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 17 Europe Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 18 Europe Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 19 UK Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 20 UK Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 21 UK Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 22 Germany Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 23 Germany Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 24 Germany Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 25 France Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 26 France Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 27 France Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 28 Italy Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 29 Italy Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 30 Italy Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 31 Spain Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 32 Spain Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 33 Spain Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 38 Japan Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 39 Japan Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 40 Japan Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 41 China Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 42 China Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 43 China Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 44 India Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 45 India Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 46 India Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 47 Australia Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 48 Australia Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 49 Australia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 50 South Korea Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 51 South Korea Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 52 South Korea Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 53 Latin America Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 54 Latin America Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 55 Latin America Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 56 Latin America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 57 Brazil Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 58 Brazil Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 59 Brazil Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 60 Mexico Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 61 Mexico Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 62 Mexico Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 63 Argentina Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 64 Argentina Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 65 Argentina Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 69 Middle East & Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 70 South Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 71 South Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 72 South Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 76 UAE Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 77 UAE Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 78 UAE Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Nanomedicine market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping
Fig. 15 Nanomedicine market: Application Movement Analysis
Fig. 16 Nanomedicine market: Indication Movement Analysis
Fig. 17 Nanomedicine market: Molecule Type Movement Analysis
Fig. 18 Regional Marketplace: Key Takeaways
Fig. 19 Regional Outlook, 2018 & 2030
Fig. 20 North America Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 21 U.S. Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 22 Canada Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 23 Europe Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 24 UK Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 25 Germany Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 26 France Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 27 Italy Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 28 SpainNanomedicine market, 2018 - 2030 (USD Million)
Fig. 29 Asia Pacific Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 30 Japan Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 31 China Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 32 India Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 33 South Korea Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 34 Australia Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 35 Latin America Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 36 Brazil Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 37 Mexico Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 38 Argentina Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 39 MEA Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 40 South Africa Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 41 Saudi Arabia Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 42 UAE Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Nanomedicine market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping
Fig. 15 Nanomedicine market: Application Movement Analysis
Fig. 16 Nanomedicine market: Indication Movement Analysis
Fig. 17 Nanomedicine market: Molecule Type Movement Analysis
Fig. 18 Regional Marketplace: Key Takeaways
Fig. 19 Regional Outlook, 2018 & 2030
Fig. 20 North America Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 21 U.S. Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 22 Canada Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 23 Europe Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 24 UK Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 25 Germany Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 26 France Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 27 Italy Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 28 SpainNanomedicine market, 2018 - 2030 (USD Million)
Fig. 29 Asia Pacific Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 30 Japan Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 31 China Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 32 India Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 33 South Korea Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 34 Australia Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 35 Latin America Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 36 Brazil Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 37 Mexico Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 38 Argentina Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 39 MEA Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 40 South Africa Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 41 Saudi Arabia Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 42 UAE Nanomedicine market, 2018 - 2030 (USD Million)
